Freestone Capital Holdings LLC Purchases 72 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Freestone Capital Holdings LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,535 shares of the medical equipment provider’s stock after acquiring an additional 72 shares during the period. Freestone Capital Holdings LLC’s holdings in Intuitive Surgical were worth $3,933,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of ISRG. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $31,000. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $33,000. Finally, Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $36,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 12,598 shares of company stock valued at $7,223,467. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $568.02 on Thursday. The stock’s fifty day moving average price is $571.70 and its 200 day moving average price is $530.90. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market cap of $202.32 billion, a price-to-earnings ratio of 88.61, a PEG ratio of 5.85 and a beta of 1.43.

Analyst Ratings Changes

ISRG has been the topic of a number of research analyst reports. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Raymond James boosted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. UBS Group boosted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Finally, Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.